Table 2.
CCl4 model | Treatment | WBCa (109/l) | PLTb (109/l) | RBCc (1012/l) | HGBd (mmol/l) | HCTe (%) |
---|---|---|---|---|---|---|
Acute | Buffer | 6.5 ± 0.8 | 512 ± 116 | 9.1 ± 0.5 | 8.8 ± 0.4 | 46 ± 0 |
siLuci | 7.9 ± 1.3 | 461 ± 56 | 8.4 ± 0.4 | 7.6 ± 0.7 | 43 ± 0 | |
siFoxf1 | 6.3 ± 0.5 | 687 ± 77 | 8.3 ± 0.4 | 7.9 ± 0.4 | 42 ± 0 | |
Chronic | Buffer | 6.3 ± 0.6 | 1302 ± 72 | 8.4 ± 0.1 | 7.5 ± 0.3 | 42 ± 0 |
siLuci | 8.4 ± 2.9 | 980 ± 158 | 7.3 ± 0.7 | 6.8 ± 0.7 | 36 ± 1.0 | |
siFoxf1 | 5.3 ± 0.5 | 658 ± 137* | 7.8 ± 0.3 | 7.2 ± 0.3 | 38 ± 1.0 |
Note: Values are given as means ± SEM. Significance of differences between the groups was tested by one way ANOVA (*p < 0.05 vs. buffer).
leukocytes.
bblood platelets.
cerythrocytes.
dhemoglobin.
ehematocrit.